BCL-2 TARGETED STRUCTURAL BASED COMPUTER AIDED DRUG DESIGN (CAAD) FOR THERAPEUTIC ASSESSMENT OF RICIN IN PROSTATE CANCER. International Journal of Pharmaceutical Sciences and Drug Research, [S. l.], v. 7, n. 2, p. 168–171, 2018. DOI: 10.25004/IJPSDR.2015.070207. Disponível em: https://ijpsdronline.com/index.php/journal/article/view/406.. Acesso em: 21 sep. 2025.